Format
Sort by

Send to

Choose Destination

Search results

Items: 10

1.

Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide.

Markowski MC, Frick KD, Eshleman JR, Luo J, Antonarakis ES.

Prostate. 2016 Dec;76(16):1484-1490. doi: 10.1002/pros.23232.

PMID:
27404039
2.

Early use of chemotherapy in metastatic prostate cancer.

Markowski MC, Carducci MA.

Cancer Treat Rev. 2016 Oct 3. pii: S0305-7372(16)30097-4. doi: 10.1016/j.ctrv.2016.09.017. [Epub ahead of print] Review.

PMID:
27720577
3.

Lumbosacral Plexus Involvement as the First Site of Metastatic Recurrence in a Patient With CTNNB1-Mutant Prostate Cancer.

Markowski MC, Wobker SE, Strowd RE 3rd, Antonarakis ES.

Clin Genitourin Cancer. 2016 Aug;14(4):e417-22. doi: 10.1016/j.clgc.2016.02.001. No abstract available.

PMID:
26992487
4.

Sarcomatoid Carcinoma of the Prostate: Retrospective Review of a Case Series From the Johns Hopkins Hospital.

Markowski MC, Eisenberger MA, Zahurak M, Epstein JI, Paller CJ.

Urology. 2015 Sep;86(3):539-43. doi: 10.1016/j.urology.2015.06.011.

5.

Therapy decisions for the symptomatic patient with metastatic castration-resistant prostate cancer.

Markowski MC, Pienta KJ.

Asian J Androl. 2015 Nov-Dec;17(6):936-8; discussion 938. doi: 10.4103/1008-682X.150843. Review.

6.

Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats.

Kass DJ, Rattigan E, Kahloon R, Loh K, Yu L, Savir A, Markowski M, Saqi A, Rajkumar R, Ahmad F, Champion HC.

PLoS One. 2012;7(4):e35388. doi: 10.1371/journal.pone.0035388.

7.

A severe case of cefoxitin-induced immune hemolytic anemia.

Leaf DE, Langer NB, Markowski M, Garratty G, Diuguid DL.

Acta Haematol. 2010;124(4):197-9. doi: 10.1159/000320169.

PMID:
21042010
8.

Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1.

Markowski MC, Bowen C, Gelmann EP.

Cancer Res. 2008 Sep 1;68(17):6896-901. doi: 10.1158/0008-5472.CAN-08-0578.

9.

Role of ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells.

Kimura K, Markowski M, Edsall LC, Spiegel S, Gelmann EP.

Cell Death Differ. 2003 Feb;10(2):240-8.

10.

Androgen blocks apoptosis of hormone-dependent prostate cancer cells.

Kimura K, Markowski M, Bowen C, Gelmann EP.

Cancer Res. 2001 Jul 15;61(14):5611-8.

Items per page

Supplemental Content

Loading ...
Support Center